A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190

Clinical trial NCT04455230 · COMPLETED

Trial details

NCT number: NCT04455230
Sponsor: Spur Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Fabry Disease Lysosomal Storage Diseases

Start date: 2020-09-08
Primary completion: 2023-09-28
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.